chartexchange

IGC
IGC Pharma, Inc.
stockNYSEAMERICAN

At CloseNov 18, 2026 3:57:27 PM EST
0.19USD+2.076%(+0.00)678,505
Pre-marketNov 18, 2026 9:14:30 AM EST
0.19USD+1.118%(+0.00)
After-hoursNov 18, 2026 4:10:30 PM EST
0.1946USD+1.460%(+0.0028)
Loading…
Loading…
Healthcare
Biotechnology
CEO
Ram Mukunda
HQ
Potomac, MD, USA
Previous Close
$0.19
Beta
1.10
52-Week High
$0.36 2025-12-17
52-Week Low
$0.08 2026-10-29
SMA 50
$0.25
SMA 200
$0.27
Avg. Vol 10D
429,428
Avg. Vol 30D
484,431
Avg. Vol 90D
642,507
Relative Vol
1.41
116.69M
86.49M
0.5600%
5,700,000
17,539
Apr 19, 2013 · 1-for-10 (reverse)
IGC Profile

igc is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. these include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening our mission is to treat pain, ptsd, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments

IGC Performance
PeriodPriceDateChangeBeta
1W0.202026-11-11-2.97%-4.163
1M0.242026-10-19-20.25%0.948
3M0.282026-08-18-32.14%1.114
6M0.292026-05-18-32.52%1.035
1Y0.342025-11-18-42.39%1.097
2Y0.352024-11-18-45.01%—
5Y1.442021-11-18-86.60%0.785
IGC Stock Summary

IGC Pharma, Inc. (NYSEAMERICAN:IGC) stock price today is $0.19, and today's volume is 684,076. IGC is up 2.714% today. The 30 day average volume is 484,431. IGC market cap is $22.52M with 116.69M shares outstanding.